Clinical trial condition

HCC

Explore clinical trials studying HCC. Study availability and eligibility vary by location and protocol.

98 public trials 29 recruiting studies

Refine in advanced search Browse all conditions

HCC trial results

Active, not recruiting

CXD101 in Immunotherapy-related Liver Cancer

NCT05873244

Conditions: HCC
Locations: Department of Clinical Oncology, Prince of Wales Hospital Hong Kong

School of Biomedical Science, The Chinese University of Hong Kong Hong Kong

View Trial Details

Active, not recruiting

IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma

NCT06757881

Conditions: HCC
Locations: Zhongshan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Active, not recruiting

Pembrolizumab in Hepatocellular Carcinoma

NCT03419481

Conditions: HCC
Locations: Department of Clinical Oncology, Prince of Wales Hospital Hong Kong

View Trial Details

Active, not recruiting

Cabozantinib in Hepatocellular Carcinoma

NCT04588051

Conditions: HCC
Locations: Department of Clinical Oncology, Prince of Wales Hospital Hong Kong

ASAN Medical Center Seoul, South Korea

View Trial Details

Active, not recruiting

Efficacy and Safety of Pracytarabine Versus Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma

NCT07300488

Conditions: HCC
Locations: Nanjing Tianyinshan Hospital Nanjing, Jiangsu, China

View Trial Details

Active, not recruiting

A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence

NCT07009470

Conditions: HCC
Locations: Tongji Hospital Wuhan, Hubei, China

View Trial Details

Active, not recruiting

Composite Warming Strategy Reduces Intraoperative Hypothermia in Open Hepatectomy for Liver Cancer

NCT06766773

Conditions: HCC
Locations: The First People's Hospital of Neijiang Neijiang, Sichuan, China

View Trial Details

Completed

A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib

NCT01387555

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations: Moores University of California San Diego Cancer Center La Jolla, California, United States

Chao Family Comprehensive Cancer Center Orange, California, United States

California Pacific Medical Center San Francisco, California, United States

Stanford Hospital and Clinics Stanford, California, United States

View all 38 locations

View Trial Details

Completed

ICIs With and Without MWA in Advanced Hepatocellular Carcinoma

NCT06581497

Conditions: HCC, Therapy Adverse Effect
Locations: The Second People's Hospital of Neijiang City Neijiang, Sichuan, China

View Trial Details

Completed

A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer

NCT01356628

Conditions: Advanced Hepatocellular Carcinoma, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

HCC

HCC trial results

Related conditions